CANbridge Pharmaceuticals Inc.
HKEX:1228.HK
0.295 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -378.837 | -483.475 | -1,077.006 | -846.043 | -217.675 |
| Depreciation & Amortization
| 28.46 | 21.978 | 15.706 | 17.839 | 3.595 |
| Deferred Income Tax
| 0 | 33.565 | -42.207 | 23.297 | 3.557 |
| Stock Based Compensation
| 19.917 | 26.822 | 30.51 | 14.655 | 16.69 |
| Change In Working Capital
| 28.081 | 118.949 | 23.019 | 45.999 | -9.735 |
| Accounts Receivables
| -12.174 | -9.913 | -2.101 | -6.603 | -0.193 |
| Inventory
| 1.041 | 3.624 | -12.895 | 0.066 | -3.02 |
| Accounts Payables
| 0 | 9.913 | 2.101 | 6.603 | 0.193 |
| Other Working Capital
| -51.3 | 115.325 | 35.914 | 45.933 | -6.715 |
| Other Non Cash Items
| -2.029 | 1.182 | 462.908 | 592.605 | 77.393 |
| Operating Cash Flow
| -278.231 | -280.979 | -587.07 | -151.648 | -126.175 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -40.86 | -34.786 | -5.332 | -153.483 | -42.476 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 41.396 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | -12 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 12 |
| Other Investing Activites
| 14.005 | -19.589 | 131.426 | -150.912 | -41.34 |
| Investing Cash Flow
| -26.855 | -34.786 | 126.094 | -153.483 | -42.42 |
| Financing Activities: | |||||
| Debt Repayment
| -7.75 | -34.006 | -24.506 | -14.246 | -1 |
| Common Stock Issued
| 0.076 | 0.034 | 563.804 | 0.985 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.64 | 13.268 | 315.012 | 692.524 | 97.967 |
| Financing Cash Flow
| -28.017 | -20.704 | 854.31 | 679.263 | 96.967 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 6.847 | 41.811 | -8.323 | -27.201 | 0.261 |
| Net Change In Cash
| -326.256 | -294.658 | 385.011 | 346.931 | -71.367 |
| Cash At End Of Period
| 124.901 | 451.157 | 745.815 | 360.804 | 13.873 |